CINCINNATI–(BUSINESS WIRE)–To recognize and honor exceptional Environmental Services (EVS) technicians, Cintas Corporation (Nasdaq: CTAS) is accepting nominations for its 2022 C.A.P.E. Awards (Cleaning to Advance the Patient Experience) through August 8, 2022. The C.A.P.E. Awards celebrate EVS staff in acute or long-term care facilities who are at the frontline of patient care, providing clean and … [Read more…]
52,000-square-foot corporate headquarters in San Diego with R&D and GMP manufacturing center Builds on current capability at Artiva’s partner, GC Cell’s facility in Republic of Korea Custom-built GMP manufacturing center further enables Artiva’s leadership position in scaled, off-the-shelf NK and CAR-NK therapeutic manufacturing for treatment of solid and hematological cancers SAN DIEGO–(BUSINESS WIRE)–#CARNK—Artiva Biotherapeutics, Inc., … [Read more…]
NEW YORK–(BUSINESS WIRE)–Best In Class MD (BICMD) announced its expansion of expert medical opinion (EMO) services to include 72 subspecialties within Internal Medicine, Surgery, Psychiatry, Radiology, Oncology and Obstetrics & Gynecology. This major initiative will double the company’s Expert Network by the end of 2022 to include over 350 fellowship-trained medical doctors. The strategic decision … [Read more…]
black-ish and Law & Order actor Anthony Anderson hosts journey to bring together descendants of siblings separated during the mid-1800s LEHI, Utah–(BUSINESS WIRE)–Today, Ancestry®, the leader in family history, announced the premiere of a powerful new film – “A Dream Delivered: The Lost Letters of Hawkins Wilson” – which brings to light a family reunion … [Read more…]
AUSTIN, Texas & LONDON–(BUSINESS WIRE)–Babylon (NYSE:BBLN) is set to join the broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, according to a preliminary list of additions posted June 3. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as … [Read more…]
TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) today announced that the first patient was dosed in the global TROPION-Breast02 phase 3 trial evaluating the efficacy and safety of datopotamab deruxtecan (Dato-DXd) versus investigator’s choice of chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic triple negative breast cancer (TNBC) not eligible … [Read more…]
Joseph M. Patti, Ph.D., Appointed President and CEO John J. Kaiser, Retires as CEO, Remains as Board Director RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Evecxia Therapeutics, a clinical stage biopharmaceutical company dedicated to realizing the therapeutic potential of serotonin synthesis amplification for the treatment of brain disorders, today announced that Joseph M. Patti, Ph.D., has been appointed … [Read more…]
Lauren Cohen Recently Joined as Vice President of Marketing and Communications NEWTON, Mass.–(BUSINESS WIRE)–, June 13, 2022 —Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced it is building a commercial team to prepare for market launch of the Lumicell Direct Visualization System (DVS), which includes its … [Read more…]
Expanded relationship will build upon established processes initiated in 2019 to meet ASC Therapeutics clinical program WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories International, Inc. (NYSE: CRL) and ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in vivo gene replacement, gene editing and allogeneic cell therapies, today announced they have agreed to … [Read more…]
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System (“ALLY” or “ALLY System”). ALLY is the first FDA-cleared platform … [Read more…]
